Aetna Inc (AET) 116.73 $AET Aetna Executive to Present

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Aetna Inc (AET) 116.73 $AET

Aetna Executive to Present at Morgan Stanley Global Healthcare Conference
BusinessWire - Thu Sep 01, 3:30PM CDT
Aetna (NYSE: AET) announced today that Shawn M. Guertin, executive vice president and chief financial officer, is scheduled to present at the Morgan Stanley Global Healthcare Conference on Tuesday, September 13 at 12:55 p.m. ET.
AET: 116.73 (+0.57), MS: 31.89 (-0.02)

Aetna and Commonwealth Health Create Product-Based High-Performance Network
BusinessWire - Wed Aug 31, 7:45AM CDT
Aetna (NYSE:AET) and Commonwealth Health are collaborating to establish a high-performance network that includes the introduction of a new health plan. The joint effort is aimed at improving the quality of patient care, creating new choices for consumers, and lowering overall health care costs.
AET: 116.73 (+0.57)

After a String of Obamacare Exits, What's Up for HMO Stocks?
Zacks Equity Research - Zacks Investment Research - Tue Aug 23, 10:16AM CDT
The health insurance industry has been creating a lot of noise lately with players cribbing about their bad experience in the individual exchange business.
CI: 128.18 (+0.54), ANTM: 124.24 (+0.88), UNH: 136.61 (+0.87), AET: 116.73 (+0.57), HUM: 177.33 (+0.80)

Molina Healthcare Eyes Growth Despite Escalating Expenses
Zacks Equity Research - Zacks Investment Research - Tue Aug 23, 9:08AM CDT
On Aug 23, we issued an updated research report on Molina Healthcare Inc. (MOH).
AET: 116.73 (+0.57), MOH: 55.33 (+1.79), UAM: 6.98 (-0.29), HUM: 177.33 (+0.80)

Did Target & Walmart Prove Retail is Back?
Ryan McQueeney - Zacks Investment Research - Fri Aug 19, 3:02PM CDT
On today's episode of the Zacks Friday Finish Line podcast the hosts take on earnings from Target (TGT) and Walmart (WMT). Did these companies prove that retail is back?
GEO: 20.85 (+1.17), CXW: 16.05 (+0.41), TGT: 70.81 (+0.23), WMT: 72.50 (-0.34), AET: 116.73 (+0.57)

Forget Aetna (AET), Buy These HMO Stocks Instead
Zacks Equity Research - Zacks Investment Research - Thu Aug 18, 9:48AM CDT
An underperforming public exchange business and regulatory attacks on the proposed acquisition of Humana are lately hassling health insurer Aetna Inc. (AET).
UNH: 136.61 (+0.87), WCG: 114.28 (+1.58), AET: 116.73 (+0.57), HUM: 177.33 (+0.80)

Business Highlights
By The Associated Press - AP - Tue Aug 16, 4:55PM CDT
___
F: 12.50 (+0.06), UNH: 136.61 (+0.87), GOOGL: 796.87 (+5.47), BKS: 11.53 (+0.10), INTC: 36.08 (+0.06), GOOG: 771.46 (+2.68), AET: 116.73 (+0.57), HUM: 177.33 (+0.80)


Insurers continue to abandon ACA exchanges, limiting choice
By TOM MURPHY - AP - Tue Aug 16, 2:44PM CDT
Aetna will abandon Affordable Care Act insurance exchanges next year in more than two-thirds of the counties where it now sells the coverage, the latest in a string of defections by big insurers that will limit customer choice in many markets.
CI: 128.18 (+0.54), UNH: 136.61 (+0.87), AET: 116.73 (+0.57), HUM: 177.33 (+0.80)

Aetna (AET) is Reducing it's Participation in Obamacare Significantly
Zacks Premium Research - Zacks Investment Research - Tue Aug 16, 1:35PM CDT
Next year, Aetna will exit close to 70% of the counties where it currently offers public on-exchange individual plans.
UNH: 136.61 (+0.87), AET: 116.73 (+0.57), HUM: 177.33 (+0.80)

Aetna (AET) to Quit 11 State Exchanges to Check Losses
Zacks Equity Research - Zacks Investment Research - Tue Aug 16, 9:57AM CDT
Aetna (AET) is mulling to pull back its public exchange business in 11 states after suffering steep losses.
ANTM: 124.24 (+0.88), UNH: 136.61 (+0.87), AET: 116.73 (+0.57), HUM: 177.33 (+0.80)

Aetna to Narrow Individual Public Exchange Participation
BusinessWire - Mon Aug 15, 7:00PM CDT
Aetna (NYSE: AET) Chairman and CEO Mark T. Bertolini made the following statement with regard to the company's 2017 participation in the Affordable Care Act individual public exchanges:
AET: 116.73 (+0.57)

Invitae Announces Second Quarter 2016 Financial Results, Secures Contract with a National Payer and Expands Its Network of Regional Private Payers
BusinessWire - Mon Aug 08, 3:00PM CDT
--- Nearly tripled volume with more than 12,000 test reports delivered -
NVTA: 8.51 (+0.17), AET: 116.73 (+0.57)

Top 3 Research Reports for August 8, 2016
Sheraz Mian - Zacks Investment Research - Mon Aug 08, 11:27AM CDT
Top 3 Research Reports for August 8, 2016
CAH: 79.73 (+0.03), TROW: 69.27 (+0.52), KHC: 89.61 (+0.13), BAC: 16.00 (+0.02), AET: 116.73 (+0.57), MA: 97.89 (+0.27)

Aetna Well Poised But for Public Exchange, Regulator Worries
Zacks Equity Research - Zacks Investment Research - Mon Aug 08, 7:43AM CDT
Performance of Aetna's (AET) Government business also, its international business offers diversification benefits, is in troubled waters with the regulators
UNH: 136.61 (+0.87), AET: 116.73 (+0.57), MOH: 55.33 (+1.79), HUM: 177.33 (+0.80)

Select Medical (SEM) Lags Q2 Earnings, Revises 2016 View
Zacks Equity Research - Zacks Investment Research - Mon Aug 08, 7:31AM CDT
Select Medical Holdings Corp. (SEM) reported second-quarter 2016 earnings of 23 cents per share, which missed the Zacks Consensus Estimate of 24 cents by 4.2%
UNH: 136.61 (+0.87), SEM: 12.12 (+0.37), AET: 116.73 (+0.57), HUM: 177.33 (+0.80)

Watch for Aetna to Potentially Pullback After Gaining 2.06% Yesterday
Comtex SmarTrend(R) - Fri Aug 05, 12:41PM CDT
Aetna (NYSE:AET) traded in a range yesterday that spanned from a low of $116.38 to a high of $119.87. Yesterday, the shares gained 2.1%, which took the trading range above the 3-day high of $117.71 on volume of 1.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
AET: 116.73 (+0.57)

Are Health Insurance Stock Investors Rooting For Donald Trump?
Ryan McQueeney - Zacks Investment Research - Thu Aug 04, 2:49PM CDT
Obamacare continues to be a hot political issue, and with a contentious election around the corner, investors might already be looking at which candidates will help or hurt the healthcare industry.
UNH: 136.61 (+0.87), AET: 116.73 (+0.57)

Humana (HUM) Q2 Earnings & Revenues Beat, Revises View
Zacks Equity Research - Zacks Investment Research - Wed Aug 03, 1:34PM CDT
Humana Inc.'s (HUM) second-quarter 2016 operating earnings per share of $2.30 beat the Zacks Consensus Estimate of $2.26 by 1.8%.
ANTM: 124.24 (+0.88), UNH: 136.61 (+0.87), AET: 116.73 (+0.57), HUM: 177.33 (+0.80)

Why Are Health Insurers Ditching Obamacare?
Ryan McQueeney - Zacks Investment Research - Wed Aug 03, 1:10PM CDT
Aetna joins a growing list of health insurance companies that are struggling to make money from the Affordable Care Act. Is Obamacare doomed to fail?
CI: 128.18 (+0.54), ANTX: 42.76 (+0.20), UNH: 136.61 (+0.87), AET: 116.73 (+0.57), HUM: 177.33 (+0.80)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

DEFSEC Completes 9-to-1 Share Consolidation

Updated Category News Views 0

DEFSEC Technologies Tightens the Belt So, DEFSEC Technologies just pulled off something that'll kick up dust among investors. A 9-to-1 share consolidation—now that's no small fry. For those riding the NASDAQ or the TSX Venture with a tight grip on their DEFSEC shares, it's strictly business today. Post-consolidation, DEFSEC's common shares are set to trade under the...

Continue Reading
Midea's R290 Tech: Real Green Cooling Revolution?

Updated Category News Views 177

A Fresh Breeze in Sustainable Cooling In the middle of Kigali’s innovation oasis, Midea RAC stood out at MOP38, the 38th Meeting of the Parties to the Montreal Protocol, flexing its sustainable tech muscles. We're talking about their R290 air conditioning technology—a natural refrigerant with zero ozone footprint and a global warming potential of a mere three. This is...

Continue Reading
Gayatri Pariwar Celebrates 100 Years with Massive Yoga Event

Updated Category News Views 52

An Impressive Centenary for Gayatri Pariwar Sometimes, you get hit by a wave so big you can't ignore it, and Gayatri Pariwar's centennial festival in New Delhi was one such tsunami. Picture this: countless souls gathered to mark a hundred years of spiritual and social reform, not just with chants and talks, but through an awe-inspiring mass yoga event. In my decades...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 231

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 459

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Sue Egstrand to Lead Karo's Next Growth Phase

Updated Category News Views 23

A New Captain at Karo’s Helm Karo Healthcare is bracing for an exciting ride. Sue Egstrand’s appointment as the new CEO pulls the curtain on what might just be a game-changing era for the company. Set to take the wheel on January 1, 2027, Egstrand brings a heavy-hitting resume—a mash-up of pharmaceutical prowess and a deep-dive into consumer healthcare. Sue’s...

Continue Reading
LongueVue Capital: Betting Big on Sports & Entertainment

Updated Category News Views 54

LongueVue Capital's Bold Move You don’t always hear about private equity firms diving head-first into the sports and entertainment sector, but LongueVue Capital (LVC) is doing just that. This New Orleans-based firm is shifting its gears and setting sights on founder-owned ventures crucial to these industries. They’re asking the key question: Why focus on just the...

Continue Reading
Vipshop Prepares for Q3 Financial Results Release

Updated Category News Views 46

Countdown to Vipshop's Third Quarter Results November 24th might just be another day on the calendar for some, but for those of us keeping tabs on the markets, it's a make-or-break moment for Vipshop Holdings Limited. The off-price retail titan from China, trailing under the ticker NYSE:VIPS, is gearing up to swing the doors wide open on its third-quarter financial...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 373

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading
HKEX Unveils New Offshore RMB Bond Index

Updated Category News Views 142

Here's the scoop: Hong Kong Exchanges and Clearing Limited (HKEX) just rolled out something worth eyeing—the HKEX Offshore RMB Bond Index. It's the first of its kind from HKEX, catered to those Dim Sum bonds floating around in the city. With Bloomberg lending a hand on the index smarts, this step is poised to give Hong Kong a leg up in the global financial marathon....

Continue Reading

Top 5 Most Recently Viewed Articles

Insigneo Welcomes Esteban Diaz to Enhance Wealth Management

Updated Category News Views 159

Insigneo Strengthens Its Wealth Management Team Insigneo, a prominent name in wealth management, proudly announces the addition of Esteban Diaz as Senior Vice President. This significant recruitment is part of the firm’s ongoing commitment to enhancing its network, particularly in serving high-net-worth clients in the Latin American region. About Esteban Diaz's...

Continue Reading
Exploring RBC Bearings: A Five-Year Investment Journey

Updated Category News Views 172

RBC Bearings: A Strong Investment Over Time RBC Bearings has proven to be a formidable player in the market, showcasing impressive performance over the last five years. With an average annual return of 18.74%, any investment made during this period would have reaped considerable rewards. The Growth of a $1000 Investment Imagine if you had decided to invest $1000 in RBC...

Continue Reading
ANI Pharmaceuticals Enhances Ophthalmology Strategy with Experts

Updated Category News Views 227

ANI Pharmaceuticals Launches FutureVision Advisory Council In a strategic move to bolster its ophthalmology and retina franchise, ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) has established the FutureVision Advisory Council. This dedicated council aims to guide the ongoing innovations within ANI's Rare Disease portfolio, focusing particularly on ophthalmological care....

Continue Reading
Unlocking Financial Freedom: The CESUR Mining Game Changer

Updated Category News Views 99

Understanding CESUR Mining and Its Impact CESUR Mining is quickly becoming a significant player in the world of cryptocurrency. This innovative platform enables users to tap into the potential of cloud mining, allowing them to earn passive income without the need for technical knowledge or constant monitoring. Established with the vision to simplify the mining process,...

Continue Reading
Understanding Nvidia's Role in the S&P 500 Market Dynamics

Updated Category News Views 204

Nvidia's Influence on the S&P 500 Market The stock market can be quite a wild ride, with swings that can astonish even the most experienced investors. Recently, stocks started off relatively flat but soon encountered volatility, leading to a significant rally largely fueled by news surrounding Nvidia. This surge prompts important questions about how the S&P 500 will...

Continue Reading